Wealth Enhancement Trust Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Wealth Enhancement Trust Services's BMY Position: Q2 2026 in Review
Wealth Enhancement Trust Services increased its Bristol-Myers Squibb (BMY) stake by 87% in Q2 2026, buying an estimated $64.5K and bringing the position to 2,412 shares worth $139K. The position accounts for 0.02% of the portfolio, ranked #324.
Wealth Enhancement Trust Services first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,009 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Wealth Enhancement Trust Services held 2,412 shares of Bristol-Myers Squibb worth $139K as of Q2 2026.
- Wealth Enhancement Trust Services bought 1,124 Bristol-Myers Squibb shares in Q2 2026, an estimated $64.5K.
- Bristol-Myers Squibb made up 0.02% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #324 holding.
- Wealth Enhancement Trust Services first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,009 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.